HY-16200-10mg
|
MedChemexpress LLC
|
Ethynylcytidine [CAS 180300-43-0]
|
|
Cancer-programmed cell death
|
|
HY-16200-25mg
|
MedChemexpress LLC
|
Ethynylcytidine [CAS 180300-43-0]
|
|
Cancer-programmed cell death
|
|
HY-16200-5mg
|
MedChemexpress LLC
|
Ethynylcytidine [CAS 180300-43-0]
|
|
Cancer-programmed cell death
|
|
HY-16200-1mL
|
MedChemexpress LLC
|
Ethynylcytidine [CAS 180300-43-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-B1075-100mg
|
MedChemexpress LLC
|
Fosfomycin (calcium) [CAS 26016-98-8]
|
|
COVID-19-immunoregulation
|
|
HY-B1075-1mL
|
MedChemexpress LLC
|
Fosfomycin (calcium) [CAS 26016-98-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-W016420-500mg
|
MedChemexpress LLC
|
Fosfomycin (sodium) [CAS 26016-99-9]
|
|
COVID-19-immunoregulation
|
|
HY-W016420-1mL
|
MedChemexpress LLC
|
Fosfomycin (sodium) [CAS 26016-99-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B0609-10mg
|
MedChemexpress LLC
|
Fosfomycin (tromethamine) [CAS 78964-85-9]
|
|
COVID-19-immunoregulation
|
|
HY-B0609-100mg
|
MedChemexpress LLC
|
Fosfomycin (tromethamine) [CAS 78964-85-9]
|
|
COVID-19-immunoregulation
|
|
HY-B0609-5mg
|
MedChemexpress LLC
|
Fosfomycin (tromethamine) [CAS 78964-85-9]
|
|
COVID-19-immunoregulation
|
|
HY-B0609-50mg
|
MedChemexpress LLC
|
Fosfomycin (tromethamine) [CAS 78964-85-9]
|
|
COVID-19-immunoregulation
|
|
HY-75920-100mg
|
MedChemexpress LLC
|
Inhoffen Lythgoe diol [CAS 64190-52-9]
|
|
|
|
HY-75920-250mg
|
MedChemexpress LLC
|
Inhoffen Lythgoe diol [CAS 64190-52-9]
|
|
|
|